Skip to main content
. 2020 Dec 10;56(12):681. doi: 10.3390/medicina56120681

Figure 1.

Figure 1

Tectorigenin reduced cell viability in glioblastoma cells. Glioblastoma GBM-8401 and GBM-8901 cells were treated with 0, 25, 50, 100, 200, and 300 μM tectorigenin for (A) 24 h and (B) 48 h. Cell viability was detected with the MTT assay. Data represent means ± standard deviation obtained from at least three independent experiments. *: p < 0.05; **: p < 0.01; ***: p < 0.001.